The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Tuesday, September 13, 2016

Komen sets goal to reduce breast cancer deaths in the U.S. by 50 percent in 10 years : abc2news





according to abc2news

Komen sets goal to reduce breast cancer deaths in the U.S. by 50 percent in 10 years

Komen sets goal to reduce breast cancer deaths in the U.S. by 50 percent in 10 years
Komen sets goal to reduce breast cancer deaths in the U.S. by 50 percent in 10 years
The Susan G. Komen breast cancer organization announced a plan today to reduce breast cancer deaths in the United States by 50 percent in 10 years.The plan involves improving access and quality, timely cancer care to those who are underserved as well as increasing their research focus on deadly breast cancers."We know that people die of breast cancer for two reasons: a lack of high-quality breast cancer care accessible to everyone, and a lack of treatments for the most aggressive and deadly forms of this disease," Dr. Judith A. Salerno, president and CEO of Susan G. Komen, said in a press release."We are taking direct action designed to solve these problems to reduce breast cancer deaths by half in the U.S. within the next decade."Salerno said the Fund II Foundation made a grant of about $27 million for a program targeting metropolitan areas to close the gap in death rates between black women and white women.


by the same token on futurity

How a diabetes drug might stop breast cancer

How a diabetes drug might stop breast cancer
How a diabetes drug might stop breast cancer
Share Article FacebookTwitterEmail You are free to share this article under the Attribution 4.0 International license.Follow Futurity RSSTwitterFacebookNewsletterScientists have discovered a way to fight the overexpression of a protein associated with the growth of breast cancer.They say pioglitazone, a drug that is typically used to treat type 2 diabetes, may offer a way to dial down levels of the protein NAF-1 and the activity of the iron-sulfur clusters it transports.Further, the findings show that a single mutation to NAF-1 almost completely blocks the ability of cancer cells to proliferate, a result that supports the idea that lowering NAF-1 expression can help stop tumors.


additionally wral

Cut breast cancer deaths in half by 2026

Cut breast cancer deaths in half by 2026
Cut breast cancer deaths in half by 2026
You must enter the characters with black color that stand out from the other charactersMessage: * A friend wanted you to see this item from WRAL.com: http://wral.com/16012030The Susan G. Komen breast cancer organization on Tuesday announced a new goal to cut deaths from breast cancer, currently 40,000 per year, in half by 2026."We know that people die of breast cancer for two reasons: a lack of high-quality breast cancer care accessible to everyone, and a lack of treatments for the most aggressive and deadly forms of this disease," said Dr. Judith A. Salerno, president and CEO of Susan G. Komen."We are taking direct action designed to solve these problems to reduce breast cancer deaths by half in the U.S. within the next decade."Komen will leverage a $27 million private donation to close the gap that sees African-American 40 percent more likely to die of breast cancer than white women."This constitutes a public health crisis that must be addressed, first in the cities where these death rates are highest, and then in all areas of the country," Salerno said.


No comments:

Post a Comment